IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 113 filers reported holding IGM BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 4.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $626,250 | -9.5% | 75,000 | 0.0% | 0.01% | -12.5% |
| Q2 2023 | $692,250 | -67.2% | 75,000 | -51.2% | 0.01% | -72.4% |
| Q1 2023 | $2,113,556 | -17.2% | 153,825 | +2.6% | 0.03% | -14.7% |
| Q4 2022 | $2,551,500 | -43.9% | 150,000 | -25.0% | 0.03% | -46.9% |
| Q3 2022 | $4,549,000 | +26.1% | 200,047 | 0.0% | 0.06% | +14.3% |
| Q2 2022 | $3,607,000 | -66.5% | 200,047 | -50.4% | 0.06% | -68.0% |
| Q1 2022 | $10,783,000 | -8.9% | 403,401 | 0.0% | 0.18% | +3.6% |
| Q4 2021 | $11,832,000 | -68.4% | 403,401 | -29.1% | 0.17% | -72.3% |
| Q3 2021 | $37,418,000 | -39.7% | 569,009 | -23.7% | 0.61% | -47.1% |
| Q2 2021 | $62,017,000 | +87.8% | 745,393 | +73.1% | 1.16% | +57.7% |
| Q1 2021 | $33,029,000 | -30.8% | 430,683 | -20.3% | 0.73% | -42.1% |
| Q4 2020 | $47,713,000 | +615.2% | 540,416 | +498.0% | 1.26% | +477.6% |
| Q3 2020 | $6,671,000 | – | 90,378 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $97,797,000 | 2.22% |
| Artal Group S.A. | 1,500,000 | $43,995,000 | 1.19% |
| Cormorant Asset Management, LP | 500,000 | $14,665,000 | 0.87% |
| Eagle Bay Advisors LLC | 34,835 | $1,022,000 | 0.65% |
| ENTRUST GLOBAL PARTNERS L L C | 66,172 | $1,940,000 | 0.54% |
| Baker Brothers Advisors | 3,156,102 | $92,568,000 | 0.45% |
| Bruce & Co., Inc. | 55,000 | $1,613,000 | 0.32% |
| Woodline Partners LP | 403,401 | $11,832,000 | 0.17% |
| Virtus ETF Advisers LLC | 5,787 | $170,000 | 0.06% |
| Alkeon Capital Management | 939,035 | $27,542,000 | 0.05% |